
David Lukton
Examiner (ID: 14183, Phone: (571)272-0952 , Office: P/1676 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1653, 1611, 1811, 1658, 1676, 1654 |
| Total Applications | 1846 |
| Issued Applications | 1076 |
| Pending Applications | 177 |
| Abandoned Applications | 596 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4988110
[patent_doc_number] => 20070154449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'TIGHT JUNCTION MODULATING PEPTIDES FOR ENHANCED MUCOSAL DELIVERY OF THERAPEUTIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 11/611289
[patent_app_country] => US
[patent_app_date] => 2006-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15170
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20070154449.pdf
[firstpage_image] =>[orig_patent_app_number] => 11611289
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/611289 | TIGHT JUNCTION MODULATING PEPTIDES FOR ENHANCED MUCOSAL DELIVERY OF THERAPEUTIC COMPOUNDS | Dec 14, 2006 | Abandoned |
Array
(
[id] => 6258413
[patent_doc_number] => 20100029903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'Polypeptide Protracting Tags'
[patent_app_type] => utility
[patent_app_number] => 12/097194
[patent_app_country] => US
[patent_app_date] => 2006-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24563
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029903.pdf
[firstpage_image] =>[orig_patent_app_number] => 12097194
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/097194 | Polypeptide Protracting Tags | Dec 12, 2006 | Abandoned |
Array
(
[id] => 5189057
[patent_doc_number] => 20070167366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'PEPTIDE WITH PUTATIVE ROLE IN CYTOSKELETAL PROTECTION'
[patent_app_type] => utility
[patent_app_number] => 11/609896
[patent_app_country] => US
[patent_app_date] => 2006-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 12439
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20070167366.pdf
[firstpage_image] =>[orig_patent_app_number] => 11609896
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/609896 | Peptide with putative role in cytoskeletal protection | Dec 11, 2006 | Issued |
Array
(
[id] => 5252823
[patent_doc_number] => 20070134279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'FAST-ACTING ORAL PEPTIDE PHARMACEUTICAL PRODUCTS'
[patent_app_type] => utility
[patent_app_number] => 11/567454
[patent_app_country] => US
[patent_app_date] => 2006-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10592
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134279.pdf
[firstpage_image] =>[orig_patent_app_number] => 11567454
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/567454 | Fast-acting oral peptide pharmaceutical products | Dec 5, 2006 | Issued |
Array
(
[id] => 5046047
[patent_doc_number] => 20070264720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Polypropylene binding peptides and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/607792
[patent_app_country] => US
[patent_app_date] => 2006-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17908
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20070264720.pdf
[firstpage_image] =>[orig_patent_app_number] => 11607792
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/607792 | Polypropylene binding peptides and methods of use | Nov 30, 2006 | Issued |
Array
(
[id] => 6589096
[patent_doc_number] => 20100062010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'NOVEL PEPTIDE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 12/095418
[patent_app_country] => US
[patent_app_date] => 2006-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13571
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20100062010.pdf
[firstpage_image] =>[orig_patent_app_number] => 12095418
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/095418 | Peptides comprising an epitope of the wilms tumor gene product | Nov 28, 2006 | Issued |
Array
(
[id] => 8555174
[patent_doc_number] => 08329646
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-11
[patent_title] => 'Methods for the treatment of muscle loss'
[patent_app_type] => utility
[patent_app_number] => 12/095477
[patent_app_country] => US
[patent_app_date] => 2006-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 4646
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12095477
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/095477 | Methods for the treatment of muscle loss | Nov 27, 2006 | Issued |
Array
(
[id] => 5297082
[patent_doc_number] => 20090012008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Pharmaceutical Composition for Photodynamic Therapy and a Method for Treating Oncological Diseases by Using Said Composition'
[patent_app_type] => utility
[patent_app_number] => 12/086284
[patent_app_country] => US
[patent_app_date] => 2006-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6054
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012008.pdf
[firstpage_image] =>[orig_patent_app_number] => 12086284
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/086284 | Pharmaceutical Composition for Photodynamic Therapy and a Method for Treating Oncological Diseases by Using Said Composition | Nov 27, 2006 | Abandoned |
Array
(
[id] => 800472
[patent_doc_number] => 07425616
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-16
[patent_title] => 'Use of C-reactive protein to treat immune complex-mediated renal disease'
[patent_app_type] => utility
[patent_app_number] => 11/604416
[patent_app_country] => US
[patent_app_date] => 2006-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4346
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/425/07425616.pdf
[firstpage_image] =>[orig_patent_app_number] => 11604416
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/604416 | Use of C-reactive protein to treat immune complex-mediated renal disease | Nov 26, 2006 | Issued |
Array
(
[id] => 10090231
[patent_doc_number] => 09127045
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-08
[patent_title] => 'Method of inhibiting bacterial growth and biofilm formation with natural quorum sensing peptides'
[patent_app_type] => utility
[patent_app_number] => 11/561275
[patent_app_country] => US
[patent_app_date] => 2006-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8956
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11561275
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/561275 | Method of inhibiting bacterial growth and biofilm formation with natural quorum sensing peptides | Nov 16, 2006 | Issued |
Array
(
[id] => 5237133
[patent_doc_number] => 20070129290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Metabolite derivatives of the HDAC inhibitor FK228'
[patent_app_type] => utility
[patent_app_number] => 11/601436
[patent_app_country] => US
[patent_app_date] => 2006-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8072
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20070129290.pdf
[firstpage_image] =>[orig_patent_app_number] => 11601436
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/601436 | Metabolite derivatives of the HDAC inhibitor FK228 | Nov 16, 2006 | Abandoned |
Array
(
[id] => 5120570
[patent_doc_number] => 20070142285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Methods of Treatment and Uses for CaMKII and Its Interaction with HDACs and Calpain'
[patent_app_type] => utility
[patent_app_number] => 11/560950
[patent_app_country] => US
[patent_app_date] => 2006-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 21158
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142285.pdf
[firstpage_image] =>[orig_patent_app_number] => 11560950
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/560950 | Methods of treatment and uses for CaMKII and its interaction with HDACs and calpain | Nov 16, 2006 | Issued |
Array
(
[id] => 4664141
[patent_doc_number] => 20080255048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Pharmaceutical Composition'
[patent_app_type] => utility
[patent_app_number] => 12/093383
[patent_app_country] => US
[patent_app_date] => 2006-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11437
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20080255048.pdf
[firstpage_image] =>[orig_patent_app_number] => 12093383
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/093383 | Pharmaceutical Composition | Nov 15, 2006 | Abandoned |
Array
(
[id] => 8244910
[patent_doc_number] => 08202837
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-19
[patent_title] => 'Methods for administering hypoglycemic agents'
[patent_app_type] => utility
[patent_app_number] => 12/092433
[patent_app_country] => US
[patent_app_date] => 2006-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3479
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/202/08202837.pdf
[firstpage_image] =>[orig_patent_app_number] => 12092433
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/092433 | Methods for administering hypoglycemic agents | Nov 2, 2006 | Issued |
Array
(
[id] => 4839286
[patent_doc_number] => 20080279771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Novel Imaging Agents for Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/091804
[patent_app_country] => US
[patent_app_date] => 2006-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10271
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20080279771.pdf
[firstpage_image] =>[orig_patent_app_number] => 12091804
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/091804 | Novel Imaging Agents for Cancer | Oct 29, 2006 | Abandoned |
Array
(
[id] => 4554734
[patent_doc_number] => 07820785
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-26
[patent_title] => 'Solid phase synthesis supports and methods'
[patent_app_type] => utility
[patent_app_number] => 11/553775
[patent_app_country] => US
[patent_app_date] => 2006-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8903
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/820/07820785.pdf
[firstpage_image] =>[orig_patent_app_number] => 11553775
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/553775 | Solid phase synthesis supports and methods | Oct 26, 2006 | Issued |
Array
(
[id] => 4634668
[patent_doc_number] => 08013120
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-06
[patent_title] => 'C-reactive protein and its use to treat systemic lupus erythematosus and related conditions'
[patent_app_type] => utility
[patent_app_number] => 12/083055
[patent_app_country] => US
[patent_app_date] => 2006-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 28
[patent_no_of_words] => 23427
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/013/08013120.pdf
[firstpage_image] =>[orig_patent_app_number] => 12083055
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/083055 | C-reactive protein and its use to treat systemic lupus erythematosus and related conditions | Oct 25, 2006 | Issued |
Array
(
[id] => 4534762
[patent_doc_number] => 07872097
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-18
[patent_title] => 'Cyclic peptide compounds'
[patent_app_type] => utility
[patent_app_number] => 12/083551
[patent_app_country] => US
[patent_app_date] => 2006-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31800
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/872/07872097.pdf
[firstpage_image] =>[orig_patent_app_number] => 12083551
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/083551 | Cyclic peptide compounds | Oct 25, 2006 | Issued |
Array
(
[id] => 303638
[patent_doc_number] => 07534776
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-19
[patent_title] => 'Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol'
[patent_app_type] => utility
[patent_app_number] => 11/586576
[patent_app_country] => US
[patent_app_date] => 2006-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2915
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/534/07534776.pdf
[firstpage_image] =>[orig_patent_app_number] => 11586576
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/586576 | Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol | Oct 25, 2006 | Issued |
Array
(
[id] => 6587803
[patent_doc_number] => 20100061932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'PEPTIDES USEFUL AS CELL-PENETRATING PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/159226
[patent_app_country] => US
[patent_app_date] => 2006-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12458
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20100061932.pdf
[firstpage_image] =>[orig_patent_app_number] => 12159226
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/159226 | PEPTIDES USEFUL AS CELL-PENETRATING PEPTIDES | Oct 24, 2006 | Abandoned |